INTELLIPHARMACEUTICS INTERNATIONAL INC. Notes Payable, Fair Value Disclosure
INTELLIPHARMACEUTICS INTERNATIONAL INC. had Notes Payable, Fair Value Disclosure of $375.25 thousand as of 2023-08-31, per its 6-K filed 2023-10-16.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Financial Instruments, Financial Liabilities, Balance Sheet Groupings
us-gaap:NotesPayableFairValueDisclosure · last filed 2024-02-06
- 2023-08-31: Notes Payable, Fair Value Disclosure $375.25K.
- 2023-05-31: Notes Payable, Fair Value Disclosure $359.45K.
- 2023-02-28: Notes Payable, Fair Value Disclosure $360.51K.
- 2022-11-30: Notes Payable, Fair Value Disclosure $360.51K.
| Period end | Notes Payable, Fair Value Disclosure |
|---|---|
| 2023-08-31 | $375.25K 6-K · filed 2023-10-16 |
| 2023-05-31 | $359.45K 6-K · filed 2023-09-26 |
| 2023-02-28 | $360.51K 6-K · filed 2023-09-26 |
| 2022-11-30 | $360.51K 20-F/A · filed 2024-02-06 |
| 2022-08-31 | $162.00K 6-K · filed 2022-10-14 |
| 2022-05-31 | $167.69K 6-K · filed 2022-07-21 |
| 2022-02-28 | $167.06K 6-K · filed 2022-04-14 |
| 2021-11-30 | $165.88K 20-F/A · filed 2024-02-06 |
| 2021-08-31 | $168.10K 6-K · filed 2021-10-15 |
| 2021-05-31 | $175.40K 6-K · filed 2021-07-15 |
| 2021-02-28 | $167.22K 6-K · filed 2021-04-14 |
| 2020-11-30 | $163.76K 20-F/A · filed 2022-05-09 |
| 2020-08-31 | $162.84K 6-K · filed 2020-10-15 |
| 2020-05-31 | $154.38K 6-K · filed 2020-07-15 |
| 2020-02-29 | $159.86K 6-K · filed 2020-05-29 |
| 2019-11-30 | $159.86K 20-F · filed 2021-03-31 |
| 2018-11-30 | $0.00 20-F · filed 2020-03-30 |